| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ef2e9f5ce8630d9b282043b8d060caff |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C275-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C275-40 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N47-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C275-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C275-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C275-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C273-00 |
| filingDate |
2014-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2016-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e29c1c651ca5d082bc80edaa39b9ae10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43a074ffe8c7c6c4d34ea8c36cf2aebc |
| publicationDate |
2016-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-9321721-B2 |
| titleOfInvention |
Kinase inhibitors |
| abstract |
The present invention relates to compounds of formula I n nor a pharmaceutically acceptable salts thereof; wherein the variables R 1 —R 5 , Ar 1 , and X are as defined herein. The compounds are capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation. |
| priorityDate |
2013-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |